Evidence map›Paper›PMID 22978529›Full record

ArticleOphthalmic epidemiology2012

Glaucoma, Alzheimer disease and other dementia: a longitudinal analysis.

Yvonne Ou, Daniel S Grossman, Paul P Lee, Frank A Sloan

Abstract read
In one paragraph

Article in Ophthalmic epidemiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Normal-tension glaucoma is associated with cognitive impairment.The British journal of ophthalmology · 2022
    Article
  12. TheOphthalmology science · 2022
    Article
  13. Article
  14. Article
  15. Ophthalmic conditions associated with dementia risk: The Cardiovascular Health Study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Longitudinal analysis of dementia diagnosis and specialty care among racially diverse Medicare beneficiaries.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yvonne OuDepartment of Ophthalmology, Duke University Eye Center, Durham, North Carolina, USA.
Daniel S Grossman
Paul P Lee
Frank A Sloan
Duke University · US

Funding

VISUAL IMPAIRMENT, TREATMENT, AND EFFECTS ON THE ELDERLYR01AG017473 · NIA · DUKE UNIVERSITY · PI SLOAN, FRANK A · 2001 to 2012
$1.7M
Visual Impairment, Treatment and Effects on the ElderlyR37AG017473 · NIA · DUKE UNIVERSITY · PI SLOAN, FRANK A · 2005 to 2008
$1.2M
NIA NIH HHS 2R37-AG-17473-05A1NIA NIH HHS R01 AG017473NIA NIH HHS R37 AG017473
6 · The paper itself

Abstract

purposeTo evaluate the risk of developing Alzheimer disease (AD) or other dementia in patients diagnosed with open-angle glaucoma (OAG) in a nationally representative longitudinal sample of elderly persons.

methodsThis retrospective cohort study (January 1, 1994-December 31, 2007) used Medicare 5% claims data. We identified beneficiaries aged 68+ years who had at least two claims with diagnoses of OAG and no Alzheimer or other dementia in 1994, using a 3-year look-back period between 1991 and 1993 (n = 63,235) and beneficiaries matched on age, sex, race, and Charlson index without a diagnosis of OAG throughout the observational period (n = 63,235), using propensity score matching. Using a Cox Proportional Hazards model, we analyzed time to AD diagnosis and time to AD or other dementia diagnosis.

resultsElderly individuals diagnosed with OAG did not have an increased rate of AD and other dementia diagnosis compared to those without OAG during a 14-year follow-up period, even after controlling for relevant covariates present at baseline.

conclusionsIndividuals aged 68+ years diagnosed with OAG have a decreased rate of AD or other dementia diagnosis compared to control patients without an OAG diagnosis. Although OAG and AD are both age-related neurodegenerative diseases, our findings do not support a positive association.

Indexed as

AgedAlzheimer DiseaseDatabases, FactualFemaleGlaucoma, Open-AngleHumansInsurance Claim ReviewIntraocular PressureLongitudinal StudiesMaleMedicareProportional Hazards ModelsRetrospective StudiesRisk AssessmentTime FactorsUnited States

Identifiers

PMID22978529
PMCPMC3523354
OpenAlexW2006109464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.